Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Nov 21, 2023
Deals

Nov. 21 Quick Takes: Merck buying neurology play Caraway

Plus: Simcere takes Greater China rights to Connect’s IL-4R program, and updates from BeiGene, Ensem, J&J, Genmab, Alto, Ascendis and more
BioCentury | Aug 8, 2023
Discovery & Translation

A circular RNA-encoded GBM target, ORM2 for NASH and more

New targets and compounds from BioCentury’s Distillery
BioCentury | Jul 31, 2023
Distillery Therapeutics

Activating TRPML1 for uranium-induced nephrotoxicity

BioCentury | Sep 10, 2020
Finance

Casma to advance muscle dystrophy candidate into the clinic with $50M series B

A $50 million series B round led by The Column Group will provide Casma with enough cash to bring its lead Duchenne muscular dystrophy program into the clinic in early 2022.  Launched in
BioCentury | Feb 28, 2020
Distillery Therapeutics

Boosting TRPML1 levels for Duchenne muscular dystrophy

BioCentury | Jun 20, 2019
Emerging Company Profile

Casma: Tailoring autophagy targets to indications

How Third Rock portfolio company Casma is evaluating the entire autophagy pathway for a broad swath of diseases
BioCentury | Jun 4, 2019
Distillery Therapeutics

TRPML1 agonists for H. pylori infections

BioCentury | Aug 17, 2017
Finance

Built to purpose

How build-to-buy deals are reaching an inflection point
Items per page:
1 - 10 of 15